A Phase III Trial of Immunotherapy-Based Combination Therapy with or without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial).

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)113-114
Number of pages2
JournalKidney Cancer
Volume5
Issue number2
DOIs
StatePublished - 2021

ASJC Scopus subject areas

  • Nephrology
  • Oncology

Cite this